High-throughput genomic studies have identified GRM1, GRM3, GRM4, GRM8 and GRIN2A as susceptibility genes in non-small-cell lung cancer (NSCLC), melanoma, osteosarcoma, and bladder cancer [23-27]. The gene discussed is GRM3; the disease is non-small cell lung carcinoma.